← SynDRA
UK-356618
SynDRA canonical compound SYN1963907 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MMP13 | MMP14 | MMP2 | MMP3 | MMP9 |
|---|
| Mechanism of action | metalloproteinase inhibitor |
|---|
All known targets
- MMP13
- MMP14
- MMP2
- MMP3
- MMP9
Mechanisms of action (all sources)
- metalloproteinase inhibitor
Cross-references
Synonyms
- UK 356618
- CHEMBL117225
- UK-356,618
- SCHEMBL6437730
- GTPL6528
- CHEBI:94305
- DTXSID50438778
- MolPort-023-277-089
- ZINC3924338
- BDBM50097263
- AKOS024458021
- FT-0675728
- PF-03890101
- UK-356618, >
- J-014983
- BRD-K57011718-001-01-5
- (R)-N*1*-[(S)-2,2-Dimethyl-1-((R)-1-phenyl-ethylcarbamoyl)-propyl]-N*4*-hydroxy-2-[3-(2-methyl-biphenyl-4-yl)-propyl]-succinamide
Look up UK-356618 in the interactive SynDRA portal →